TREATMENT
Clinical trials for TREATMENT explained in plain language.
Never miss a new study
Get alerted when new TREATMENT trials appear
Sign up with your email to follow new studies for TREATMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Custom-Made vaccine trains body to attack advanced tumors
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a personalized vaccine (Neo-DC) made from a patient's own immune cells to target unique markers on their advanced solid tumor. The vaccine aims to teach the immune system to attack the cancer. The trial enrolls 9 adults with advanced solid tumors who have not res…
Matched conditions: TREATMENT
Phase: NA • Sponsor: Fudan University • Aim: ⭐️ VACCINE ⭐️
Last updated May 22, 2026 14:03 UTC
-
Promising Triple-Drug combo targets tough leukemia mutation
Disease control Recruiting nowThis study is testing a three-drug combination (venetoclax, ivosidenib, and azacitidine) in adults with a specific genetic form of acute myeloid leukemia (AML) called IDH1-mutated. The goal is to see if this combination can improve remission rates and survival. About 23 participa…
Matched conditions: TREATMENT
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 26, 2026 03:42 UTC
-
New hope for young hodgkin patients: drug combo aims to cut radiation
Disease control Recruiting nowThis study tests a new treatment for children, teens, and young adults (ages 2 to 34) with newly diagnosed classical Hodgkin lymphoma. The drug brentuximab vedotin replaces two older drugs in the standard chemo mix, with the goal of achieving a faster complete response on PET sca…
Matched conditions: TREATMENT
Phase: PHASE2, PHASE3 • Sponsor: Children's Cancer Group, China • Aim: Disease control
Last updated May 26, 2026 03:41 UTC
-
New hope for ITP patients: antibody drug takes on standard therapy
Disease control Recruiting nowThis study compares a new drug called daratumumab with the standard drug rituximab in 160 adults with immune thrombocytopenia (ITP) whose condition did not improve or came back after steroid treatment. The goal is to see which drug works better at raising platelet counts and redu…
Matched conditions: TREATMENT
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 26, 2026 03:40 UTC
-
Can a tailored mix of quitting aids finally help stubborn smokers kick the habit?
Disease control Recruiting nowThis study enrolls 544 smokers who want to quit but have had trouble with standard medications. Participants receive free nicotine patches, lozenges, varenicline, or e-cigarettes for 12 weeks, with treatment adjusted based on individual response. All visits are remote, and the st…
Matched conditions: TREATMENT
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated May 26, 2026 03:35 UTC
-
Can ancient chinese medicine slow down early puberty?
Disease control Recruiting nowThis study tests whether a combination of Chinese herbs and tiny acupuncture needles can help girls with idiopathic precocious puberty (early puberty). The goal is to shrink or stop breast growth and keep bone age from advancing too fast. About 170 girls will be treated for six m…
Matched conditions: TREATMENT
Phase: PHASE3 • Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated May 26, 2026 03:35 UTC
-
Could stem cells heal deadly skin wounds in kidney patients?
Disease control Recruiting nowThis early-phase study tests whether stem cells from amniotic fluid can help heal painful skin wounds (calciphylaxis) in people with chronic kidney disease. Nine participants will receive the stem cell treatment, and researchers will measure wound healing and pain levels. The goa…
Matched conditions: TREATMENT
Phase: EARLY_PHASE1 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated May 26, 2026 03:32 UTC
-
New drug cocktail aims to rescue ITP patients who failed steroids
Disease control Recruiting nowThis study tests whether combining two drugs (rituximab and daratumumab) can safely raise platelet counts in adults with immune thrombocytopenia (ITP) who did not get better with steroids. About 20 participants will receive the combo and be monitored for 12 weeks. The goal is to …
Matched conditions: TREATMENT
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 26, 2026 03:31 UTC
-
New laser hope for diabetic eye disease
Disease control Recruiting nowThis study tests a special laser (micropulse) to treat diabetic macular edema, a swelling in the back of the eye that can blur vision. Researchers will compare how well it works in people getting treatment for the first time versus those who haven't improved with other treatments…
Matched conditions: TREATMENT
Sponsor: The General Authority for Teaching Hospitals and Institutes • Aim: Disease control
Last updated May 26, 2026 03:29 UTC
-
New acid blocker may beat old one in stomach bug battle
Disease control Recruiting nowThis study tests whether a newer acid-blocking drug (P-CAB) works better than a standard one (PPI) when used as part of a 4-drug therapy for H. pylori infection. About 320 adults who have not been treated before will take one of the two combinations. The goal is to see which trea…
Matched conditions: TREATMENT
Phase: NA • Sponsor: Tanta University • Aim: Disease control
Last updated May 26, 2026 02:48 UTC
-
New glasses may help kids' eyesight from getting worse
Disease control Recruiting nowThis study tests two types of special glasses lenses designed to slow the progression of nearsightedness (myopia) in children aged 6 to 14. About 120 children will wear the lenses daily for one year and have regular eye exams. The goal is to see if the lenses reduce how much the …
Matched conditions: TREATMENT
Phase: NA • Sponsor: Beijing Tongren Hospital • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New hope for kids with Hard-to-Treat ITP: daratumumab takes on rituximab
Disease control Recruiting nowThis study compares two medications, daratumumab and rituximab, in children aged 6 to 17 with immune thrombocytopenia (ITP) whose condition did not improve or came back after steroid treatment. ITP causes low platelet counts, leading to bruising and bleeding. The goal is to see w…
Matched conditions: TREATMENT
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New hope for ITP patients: drug combo aims to boost platelets
Disease control Recruiting nowThis study tests whether adding an anti-CD38 antibody to the standard drug rituximab works better than rituximab alone for adults with immune thrombocytopenia (ITP) who did not improve or relapsed after steroid treatment. The goal is to safely raise platelet counts and reduce ble…
Matched conditions: TREATMENT
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 19, 2026 11:59 UTC
-
New hope for kids with Hard-to-Treat bleeding disorder
Disease control Recruiting nowThis study tests a new drug (anti-CD38 antibody) in 60 children aged 6 and older with immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding. The drug aims to raise platelet counts safely in kids who haven't improved with standard …
Matched conditions: TREATMENT
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
Exercise overload: new study tests if High-Dose workouts heal concussions faster
Symptom relief Recruiting nowThis study tests whether a higher dose of aerobic exercise, started within two weeks of a concussion, helps teens recover faster. Researchers will measure symptom resolution, brain inflammation markers, and anxiety or depression changes. The goal is to create better rehabilitatio…
Matched conditions: TREATMENT
Phase: PHASE2 • Sponsor: University of Colorado, Denver • Aim: Symptom relief
Last updated May 26, 2026 03:38 UTC
-
Scissors vs. electrosurgery: which is better for uterine septum removal?
Symptom relief Recruiting nowThis study compares two surgical techniques for removing a uterine septum, a wall of tissue inside the uterus that can cause problems. Researchers want to see if using scissors without electricity is better than using an electric tool. The study will measure surgery time, costs, …
Matched conditions: TREATMENT
Phase: NA • Sponsor: Northwestern University • Aim: Symptom relief
Last updated May 18, 2026 12:12 UTC
-
Can a nerve block predict headache relief? new study investigates
Knowledge-focused Recruiting nowThis study is for people with medication-overuse headache, a condition where taking too much pain medicine makes headaches worse. Researchers want to find out which patient factors (like age or headache history) affect how well a nerve block injection works. 70 adults will get an…
Matched conditions: TREATMENT
Sponsor: Sultan 1. Murat State Hospital • Aim: Knowledge-focused
Last updated May 20, 2026 11:56 UTC